The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Pharma giant targets new standards of care
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The launch coincides with IBS Awareness Month in April
Subscribe To Our Newsletter & Stay Updated
